LEXICON PHARMACEUTICALS, INC. (LXRX) Insider Trading

Name: LEXICON PHARMACEUTICALS, INC. (LXRX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jun 4, 2026): Judith L. Swain (Director): Exercise/Conversion of 89,312 shares.

Get alerted when insiders trade LXRX

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta